Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 4, 2026

S&P Dow Jones Indices Consultation on Treatment of MegaCap Companies - Results

View original at finance.yahoo.com
S&P Dow Jones Indices Consultation on Treatment of MegaCap Companies - Results NEW YORK, June 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") conducted a consultation with market participants on potential changes to the S&P U.S…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • No changes will be made to the eligibility criteria including financial viability screens, seasoning period, or minimum IWF for the S&P 500, S&P MidCap 400, or S&P SmallCap 600 as a result of the consultation on the treatment of MegaCap companies.

    60% confidence
  • The decision not to adopt the proposed exceptions preserves core index principles by maintaining consistent application of key eligibility requirements.

    60% confidence
  • Exceptions to the financial viability, seasoning, and IWF requirements should not be granted solely based on market capitalization.

    60% confidence
  • The Index Committee is not bound by any comments or information submitted as part of the consultation.

    60% confidence
  • Market consultations are the primary mechanism through which the Index Committee engages with market participants to seek feedback on whether methodology changes are necessary or appropriate.

    60% confidence
  • The S&P indices can continue to meet their stated objectives while preserving their role as representative and investable benchmarks for the U.S. equity market under the existing methodology.

    60% confidence
  • Although there may be trade-offs between strict adherence to eligibility requirements and broad representativeness, the current methodology provides substantial market coverage and sector balance.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
S&P Dow Jones Indices Consultation on Treatment of MegaCap Companies - Results — Source | Via News | ViaNews Market